<DOC>
	<DOCNO>NCT00426660</DOCNO>
	<brief_summary>To provide access maraviroc patient limited therapeutic treatment option collect safety data broader patient population .</brief_summary>
	<brief_title>Expanded Access Program Maraviroc At Multiple Centers</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Subjects must fail achieve adequate virologic suppression current regimen HIV1 RNA great equal 1000 copies/ml , screen Have R5 HIV1 Screening verify Monogram Biosciences Trofile assay Minimum age must 16 year minimum adult age determine local regulatory authority direct local law . Failed prior treatment CCR5 antagonist , ongoing CCR5 trial previously prematurely discontinue Maraviroc trial</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>HIV Infections</keyword>
</DOC>